Pharmaceutical manufacturers of Methionine

Evonik is an international specialty chemicals corporation that offers a diverse array of products and solutions for the development of pharmaceutical products and the specialized manufacturing sectors. Renowned for its expertise in functional excipients, drug delivery technologies, API manufacturing, intermediates, food ingredients, amino acid derivatives, catalysts, chromatography media, and raw materials

Daiichi Sankyo is an international pharmaceutical organization with its corporate roots in Japan. We offer pioneering products and services in over 20 nations across the globe. Leveraging over a century of scientific knowledge, our company taps into a rich history of creativity and a strong lineup of promising new medications to aid patients. Through the exceptional expertise and dedication of our 15,000 staff members worldwide, we develop inventive novel and generic medications, as well as fresh approaches to drug discovery and distribution. We are driven by a dedication to innovation and a deep concern for patients worldwide who require our medications.

An Integrated pharma company with business presence in over 21 countries As a leading global security company we are committed to being at the forefront of technology and innovation, delivering superior capability in tandem with maximized cost efficiencies. This includes our markets around the world where we continue to expand our international presence, strengthen our international partnerships and broaden our focus to one that is increasingly global.

The Ajinomoto Group has advanced its purpose from “Unlocking the power of amino acids to resolve the food and health issues” to “contributing to the well-being of all human beings, our society and our planet with ‘AminoScience’.” We consider well-being to mean health and happiness. Our advanced purpose therefore represents our commitment to achieving two outcomes by 2030 which are connected by food systems: to reduce our environmental impact by 50% and to help extend the healthy life expectancy of 1 billion people.

We are utilizing the world's top-level fermentation and synthesis technologies to supply domestic and overseas users with various fine chemical products centered on amino and nucleic acids for pharmaceuticals, nutritional supplements, and industrial use, as well as the derivatives of such acids. Through the rapid progress in genome analysis seen in recent years, we anticipate the development of new biotechnology processes and products from fermentation, a technology which humankind has been utilizing since time immemorial.

Sekisui's BioProduction division provides contract development and manufacturing services for the biopharmaceutical sector. Our UK site boasts more than 40 years of extensive fermentation and purification expertise on a large scale. We specialize in the upscaling and production of enzymes, plasmids, and other proteins for biopharmaceutical production.

Since its establishment in 2003, the company has achieved successive certifications including China GMP, ISO9001, and KOSHER. In 2006, it successfully obtained the 'Certificate of Foreign Manufacturer of Pharmaceutical Products' from the Ministry of Health and Welfare of Japan. In 2013, it acquired the Rutin CEP certificate and underwent PMDA inspection in 2015. Adhering strictly to GMP guidelines, the company has established a comprehensive quality management system, ensuring effective quality control throughout the procurement, production, and sales processes through both hardware and software.